HEADER TOXIN 08-JAN-20 6VGT TITLE SOLUTION NMR STRUCTURE OF ENTEROCOCCAL CYTOLYSIN L (CYLLL") PRODUCED TITLE 2 BY ENTEROCOCCUS FAECALIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOLYSIN L; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECALIS; SOURCE 3 ORGANISM_TAXID: 1351; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LANTHIPEPTIDE, CYTOLYSIN, CYCLIC PEPTIDE, POSTTRANSLATIONAL KEYWDS 2 MODIFICATION, TOXIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.C.BOBEICA,W.A.VAN DER DONK,L.ZHU,W.TANG REVDAT 4 14-JUN-23 6VGT 1 REMARK REVDAT 3 14-JUL-21 6VGT 1 JRNL REVDAT 2 09-SEP-20 6VGT 1 COMPND REMARK LINK ATOM REVDAT 1 08-JUL-20 6VGT 0 JRNL AUTH S.C.BOBEICA,L.ZHU,J.Z.ACEDO,W.TANG,W.A.VAN DER DONK JRNL TITL STRUCTURAL DETERMINANTS OF MACROCYCLIZATION IN JRNL TITL 2 SUBSTRATE-CONTROLLED LANTHIPEPTIDE BIOSYNTHETIC PATHWAYS. JRNL REF CHEM SCI V. 11 12854 2020 JRNL REFN ISSN 2041-6520 JRNL PMID 34094481 JRNL DOI 10.1039/D0SC01651A REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.C.BOBEICA,L.ZHU,J.Z.ACEDO,W.TANG,W.A.VAN DER DONK REMARK 1 TITL CORRECTION: STRUCTURAL DETERMINANTS OF MACROCYCLIZATION IN REMARK 1 TITL 2 SUBSTRATE-CONTROLLED LANTHIPEPTIDE BIOSYNTHETIC PATHWAYS. REMARK 1 REF CHEM SCI V. 11 12871 2020 REMARK 1 REFN ISSN 2041-6520 REMARK 1 PMID 34101773 REMARK 1 DOI 10.1039/D0SC90208J REMARK 1 REFERENCE 2 REMARK 1 AUTH W.TANG,W.A.VAN DER DONK REMARK 1 TITL THE SEQUENCE OF THE ENTEROCOCCAL CYTOLYSIN IMPARTS UNUSUAL REMARK 1 TITL 2 LANTHIONINE STEREOCHEMISTRY. REMARK 1 REF NAT.CHEM.BIOL. V. 9 157 2013 REMARK 1 REFN ESSN 1552-4469 REMARK 1 PMID 23314913 REMARK 1 DOI 10.1038/NCHEMBIO.1162 REMARK 1 REFERENCE 3 REMARK 1 AUTH W.TANG,W.A.VAN DER DONK REMARK 1 TITL THE SEQUENCE OF THE ENTEROCOCCAL CYTOLYSIN IMPARTS UNUSUAL REMARK 1 TITL 2 LANTHIONINE STEREOCHEMISTRY. REMARK 1 REF NAT.CHEM.BIOL. V. 9 157 2013 REMARK 1 REFN ESSN 1552-4469 REMARK 1 PMID 23314913 REMARK 1 DOI 10.1038/NCHEMBIO.1162 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH, X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X-PLOR REMARK 3 NIH), SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X- REMARK 3 PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VGT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1000246368. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 296 REMARK 210 PH : 6 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 2.0 MM CYTOLYSIN L, METHANOL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY, NMRDRAW, NMRPIPE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ABA A 1 H CYS A 5 1.48 REMARK 500 CB ALA A 14 SG CYS A 18 1.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 DAL A 34 -84.38 -44.46 REMARK 500 3 VAL A 21 73.43 26.77 REMARK 500 5 ALA A 17 -71.96 -74.61 REMARK 500 5 TRP A 20 -79.81 -80.63 REMARK 500 5 VAL A 21 -87.89 -56.26 REMARK 500 5 LEU A 35 -15.29 -48.04 REMARK 500 6 VAL A 21 -75.53 -36.59 REMARK 500 6 HIS A 37 -62.81 -143.65 REMARK 500 7 VAL A 21 -85.05 18.07 REMARK 500 7 ILE A 25 -49.88 68.30 REMARK 500 7 LEU A 35 -18.60 -46.71 REMARK 500 8 VAL A 21 22.55 38.41 REMARK 500 9 ALA A 17 -70.49 -78.27 REMARK 500 9 VAL A 21 -147.13 30.05 REMARK 500 9 HIS A 37 -62.73 -146.50 REMARK 500 10 VAL A 33 -73.06 -50.65 REMARK 500 10 DAL A 34 -62.25 -35.12 REMARK 500 10 HIS A 37 -54.36 -128.35 REMARK 500 11 VAL A 21 -157.48 -91.87 REMARK 500 11 HIS A 37 -107.36 -150.47 REMARK 500 12 VAL A 21 -135.02 22.76 REMARK 500 12 ILE A 25 -30.02 -34.62 REMARK 500 12 HIS A 37 -83.08 -115.75 REMARK 500 14 VAL A 21 27.67 34.61 REMARK 500 14 VAL A 33 -70.40 -50.88 REMARK 500 14 HIS A 37 101.36 161.21 REMARK 500 15 ILE A 25 -51.54 69.77 REMARK 500 15 HIS A 37 107.75 160.38 REMARK 500 16 VAL A 4 -71.41 -63.87 REMARK 500 16 VAL A 21 41.39 27.36 REMARK 500 16 ILE A 25 -28.73 -34.13 REMARK 500 17 HIS A 37 105.46 162.17 REMARK 500 18 ILE A 25 -28.60 -34.68 REMARK 500 18 HIS A 37 -91.18 -112.94 REMARK 500 19 VAL A 21 -61.07 69.30 REMARK 500 19 HIS A 37 104.78 161.86 REMARK 500 20 VAL A 21 59.31 37.29 REMARK 500 20 ILE A 25 -49.55 70.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30710 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF ENTEROCOCCAL CYTOLYSIN L (CYLLL") REMARK 900 PRODUCED BY ENTEROCOCCUS FAECALIS DBREF 6VGT A 1 38 PDB 6VGT 6VGT 1 38 SEQRES 1 A 38 ABA DBU PRO VAL CYS ALA VAL ALA ALA DBU ALA ALA ALA SEQRES 2 A 38 ALA DHA ALA ALA CYS GLY TRP VAL GLY GLY GLY ILE PHE SEQRES 3 A 38 THR GLY VAL DBU VAL VAL VAL DAL LEU LYS HIS CYS HET ABA A 1 14 HET DBU A 2 11 HET DBU A 10 11 HET DHA A 15 8 HET DBU A 30 11 HET DAL A 34 9 HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM DBU (2Z)-2-AMINOBUT-2-ENOIC ACID HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM DAL D-ALANINE HETSYN DBU Z-DEHYDROBUTYRINE HETSYN DHA 2,3-DIDEHYDROALANINE FORMUL 1 ABA C4 H9 N O2 FORMUL 1 DBU 3(C4 H7 N O2) FORMUL 1 DHA C3 H5 N O2 FORMUL 1 DAL C3 H7 N O2 HELIX 1 AA1 ABA A 1 VAL A 21 1 21 HELIX 2 AA2 GLY A 23 CYS A 38 1 16 LINK C ABA A 1 N DBU A 2 1555 1555 1.33 LINK CB ABA A 1 SG CYS A 5 1555 1555 1.81 LINK C DBU A 2 N PRO A 3 1555 1555 1.31 LINK C ALA A 9 N DBU A 10 1555 1555 1.33 LINK C DBU A 10 N ALA A 11 1555 1555 1.33 LINK C ALA A 14 N DHA A 15 1555 1555 1.33 LINK C DHA A 15 N ALA A 16 1555 1555 1.33 LINK C VAL A 29 N DBU A 30 1555 1555 1.33 LINK C DBU A 30 N VAL A 31 1555 1555 1.33 LINK C VAL A 33 N DAL A 34 1555 1555 1.32 LINK C DAL A 34 N LEU A 35 1555 1555 1.33 LINK CB DAL A 34 SG CYS A 38 1555 1555 1.82 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 N ABA A 1 7.521 -12.284 -10.040 1.00 0.00 N HETATM 2 CA ABA A 1 8.293 -11.399 -9.135 1.00 0.00 C HETATM 3 C ABA A 1 7.660 -11.451 -7.750 1.00 0.00 C HETATM 4 O ABA A 1 8.321 -11.812 -6.779 1.00 0.00 O HETATM 5 CB ABA A 1 8.309 -9.973 -9.715 1.00 0.00 C HETATM 6 CG ABA A 1 7.179 -9.117 -9.118 1.00 0.00 C HETATM 7 H1 ABA A 1 6.529 -11.981 -10.056 1.00 0.00 H HETATM 8 H2 ABA A 1 7.582 -13.266 -9.693 1.00 0.00 H HETATM 9 H3 ABA A 1 7.914 -12.231 -11.000 1.00 0.00 H HETATM 10 HA ABA A 1 9.308 -11.763 -9.072 1.00 0.00 H HETATM 11 HB2 ABA A 1 8.198 -10.036 -10.794 1.00 0.00 H HETATM 12 HG1 ABA A 1 6.233 -9.436 -9.529 1.00 0.00 H HETATM 13 HG3 ABA A 1 7.161 -9.222 -8.046 1.00 0.00 H HETATM 14 HG2 ABA A 1 7.348 -8.081 -9.373 1.00 0.00 H HETATM 15 N DBU A 2 6.375 -11.111 -7.661 1.00 0.00 N HETATM 16 CA DBU A 2 5.697 -11.135 -6.425 1.00 0.00 C HETATM 17 CB DBU A 2 4.317 -11.219 -6.195 1.00 0.00 C HETATM 18 CG DBU A 2 3.262 -11.303 -7.269 1.00 0.00 C HETATM 19 C DBU A 2 6.659 -11.056 -5.265 1.00 0.00 C HETATM 20 O DBU A 2 7.413 -10.089 -5.144 1.00 0.00 O HETATM 21 H DBU A 2 5.881 -10.846 -8.466 1.00 0.00 H HETATM 22 HB DBU A 2 3.963 -11.226 -5.175 1.00 0.00 H HETATM 23 HG1 DBU A 2 3.712 -11.095 -8.228 1.00 0.00 H HETATM 24 HG2 DBU A 2 2.488 -10.578 -7.067 1.00 0.00 H HETATM 25 HG3 DBU A 2 2.835 -12.294 -7.278 1.00 0.00 H